JP2009525734A - 出産特性 - Google Patents
出産特性 Download PDFInfo
- Publication number
- JP2009525734A JP2009525734A JP2008553617A JP2008553617A JP2009525734A JP 2009525734 A JP2009525734 A JP 2009525734A JP 2008553617 A JP2008553617 A JP 2008553617A JP 2008553617 A JP2008553617 A JP 2008553617A JP 2009525734 A JP2009525734 A JP 2009525734A
- Authority
- JP
- Japan
- Prior art keywords
- region
- genetic marker
- markers
- genetic
- bovine chromosome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000002068 genetic effect Effects 0.000 claims abstract description 703
- 241000283690 Bos taurus Species 0.000 claims abstract description 459
- 238000000034 method Methods 0.000 claims abstract description 114
- 208000002254 stillbirth Diseases 0.000 claims abstract description 89
- 231100000537 stillbirth Toxicity 0.000 claims abstract description 89
- 108091092878 Microsatellite Proteins 0.000 claims abstract description 66
- 244000309466 calf Species 0.000 claims abstract description 44
- 208000010515 dystocia Diseases 0.000 claims abstract description 42
- 238000009007 Diagnostic Kit Methods 0.000 claims abstract description 8
- 239000003550 marker Substances 0.000 claims description 630
- 210000000349 chromosome Anatomy 0.000 claims description 432
- 239000002773 nucleotide Substances 0.000 claims description 44
- 125000003729 nucleotide group Chemical group 0.000 claims description 44
- 108091034117 Oligonucleotide Proteins 0.000 claims description 10
- 238000001514 detection method Methods 0.000 abstract description 11
- 230000001488 breeding effect Effects 0.000 abstract description 7
- 238000009395 breeding Methods 0.000 abstract description 5
- 238000004458 analytical method Methods 0.000 description 67
- 108090000623 proteins and genes Proteins 0.000 description 42
- 230000008774 maternal effect Effects 0.000 description 38
- 230000000694 effects Effects 0.000 description 36
- 238000012360 testing method Methods 0.000 description 36
- 239000000523 sample Substances 0.000 description 19
- 150000007523 nucleic acids Chemical class 0.000 description 18
- 239000013615 primer Substances 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 17
- 108020004707 nucleic acids Proteins 0.000 description 16
- 102000039446 nucleic acids Human genes 0.000 description 16
- 238000003752 polymerase chain reaction Methods 0.000 description 11
- 230000004983 pleiotropic effect Effects 0.000 description 10
- 230000000295 complement effect Effects 0.000 description 9
- 238000009396 hybridization Methods 0.000 description 9
- 108700028369 Alleles Proteins 0.000 description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 description 8
- 230000035772 mutation Effects 0.000 description 8
- 230000003321 amplification Effects 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000013507 mapping Methods 0.000 description 6
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 235000013365 dairy product Nutrition 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 241000042032 Petrocephalus catostoma Species 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 230000035606 childbirth Effects 0.000 description 4
- 238000001558 permutation test Methods 0.000 description 4
- 102000054765 polymorphisms of proteins Human genes 0.000 description 4
- 239000002987 primer (paints) Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- 108091093037 Peptide nucleic acid Proteins 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 102000054766 genetic haplotypes Human genes 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 3
- 239000010902 straw Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 2
- 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 2
- 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000012252 genetic analysis Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 101100022971 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SAM1 gene Proteins 0.000 description 1
- 208000035010 Term birth Diseases 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 238000012248 genetic selection Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 244000309465 heifer Species 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001869 rapid Effects 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200600181 | 2006-02-08 | ||
| DKPA200700165 | 2007-01-31 | ||
| PCT/DK2007/000060 WO2007090401A2 (en) | 2006-02-08 | 2007-02-05 | Calving characteristics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009525734A true JP2009525734A (ja) | 2009-07-16 |
| JP2009525734A5 JP2009525734A5 (enExample) | 2009-09-17 |
Family
ID=37946083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008553617A Withdrawn JP2009525734A (ja) | 2006-02-08 | 2007-02-06 | 出産特性 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090181386A1 (enExample) |
| EP (1) | EP2032717A2 (enExample) |
| JP (1) | JP2009525734A (enExample) |
| AR (1) | AR059367A1 (enExample) |
| AU (1) | AU2007214120A1 (enExample) |
| WO (1) | WO2007090401A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107760789B (zh) * | 2017-09-18 | 2021-03-02 | 中国农业科学院兰州畜牧与兽药研究所 | 一种用于牦牛亲子鉴定和个体识别的基因分型检测试剂盒 |
| AU2023250649A1 (en) | 2022-04-04 | 2024-11-14 | The Regents Of The University Of California | Genetic complementation compositions and methods |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210015A (en) * | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| WO1992013102A1 (en) * | 1991-01-15 | 1992-08-06 | Genmark | Polymorphic dna markers in bovidae |
-
2007
- 2007-02-05 US US12/223,773 patent/US20090181386A1/en not_active Abandoned
- 2007-02-05 WO PCT/DK2007/000060 patent/WO2007090401A2/en not_active Ceased
- 2007-02-06 EP EP07702478A patent/EP2032717A2/en not_active Withdrawn
- 2007-02-06 AU AU2007214120A patent/AU2007214120A1/en not_active Abandoned
- 2007-02-06 JP JP2008553617A patent/JP2009525734A/ja not_active Withdrawn
- 2007-02-08 AR ARP070100524A patent/AR059367A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007090401A8 (en) | 2008-09-25 |
| AR059367A1 (es) | 2008-03-26 |
| AU2007214120A1 (en) | 2007-08-16 |
| WO2007090401A3 (en) | 2007-11-08 |
| US20090181386A1 (en) | 2009-07-16 |
| EP2032717A2 (en) | 2009-03-11 |
| WO2007090401A2 (en) | 2007-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Crawford et al. | Sheep linkage mapping: nineteen linkage groups derived from the analysis of paternal half-sib families. | |
| Khatib et al. | Association of the protease inhibitor gene with production traits in Holstein dairy cattle | |
| US10323284B2 (en) | Single nucleotide polymorphisms associated with bull fertility | |
| AU2009275988B2 (en) | A genetic marker test for Brachyspina and fertility in cattle | |
| Kakoi et al. | Genetic diagnosis of sex chromosome aberrations in horses based on parentage test by microsatellite DNA and analysis of X‐and Y‐linked markers | |
| JP2009525734A (ja) | 出産特性 | |
| JP2009525733A (ja) | 乳房炎耐性 | |
| JP2009525733A5 (enExample) | ||
| WO2008014550A1 (en) | Markers for pigmentation | |
| US20090176224A1 (en) | Udder Health Characteristics | |
| Jedrzejczak et al. | Association between polymorphisms of CYP19, CYP21, and ER1 genes and milk production traits in Black-and-White cattle | |
| CN111363807A (zh) | Evc综合征的检测方法、检测组合物及检测试剂盒 | |
| Schwarz et al. | Methods for screening in cystic fibrosis | |
| TWI375724B (en) | Methods for identifying reproduction performance of sows based on prolactin gene and applications thereof | |
| WO2009097862A1 (en) | Genetic markers for fertility | |
| US20080118914A1 (en) | Follistatin gene as a genetic marker for first parity litter size in pigs | |
| CN101415842A (zh) | 牛乳房炎抗性的qtl | |
| WO2010108498A1 (en) | Genetic markers for mastitis resistance | |
| JP2006506995A (ja) | ソマトトロピン受容体遺伝子の多型の分析に基づいた、一定の乳生産能力を有する動物の選択のための方法及びキット | |
| JP3948702B2 (ja) | ウシのＣｌａｕｄｉｎ−１６欠損症タイプ２の遺伝子診断法 | |
| JP4430063B2 (ja) | Ｗｆｄｃ１の変異を検出する先天性眼疾患の検査方法 | |
| Van Haeringen | DNA analysis in paternity testing of dogs and cats | |
| AU2007281024B2 (en) | Markers for pigmentation | |
| Happ et al. | DLA-DRB1 histocompatibility genotyping using RT-nested PCR and cycle sequencing | |
| Class et al. | Patent application title: SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH BULL FERTILITY Inventors: Hasan Khatib (Fitchburg, WI, US) Hasan Khatib (Fitchburg, WI, US) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090724 |
|
| A300 | Application deemed to be withdrawn because no request for examination was validly filed |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20100406 |